Boyapati A, et al. High Baseline Serum IL-6 Identifies a Subgroup of Rheumatoid Arthritis Patients with Rapid Joint Damage and Clinical Progression and Predicts Increased Sarilumab Treatment Response. ACR 2018, abstract L08.
Risico op hart- en vaatziekten bij inflammatoire artritis verhoogd
jan 2024 | Arthritis psoriatica, RA, Spondyloartritis